Peptide Synthesis
The Medicilon peptide synthesis research team closely focuses on the theme of peptide drug research and is committed to solving the core issues that limit the development and application of peptide drugs. Currently, it has established the synthesis of upstream non-natural amino acid structural units, peptide drug modification, and large-scale synthesis, to a complete system for research on downstream peptide drug signal transduction pathways and mechanisms of action. Through multi-disciplinary cooperation and crossover in chemistry, biology, medicine, pharmacy, etc., the team has achieved outstanding achievements in both basic and applied research.
Service include:
-
Standard chemical peptide synthesisPeptide modificationPeptide libraryRecombinant peptide expressionMedicinal peptide synthesisStructural modificationStructural analysisPeptide functional testing
Service technology:
-
Solid-phase synthesis of peptidesCustomized amplification and synthesisBiosynthetic peptidesGene chemical synthesis
Capabilities:
-
>10g level peptide synthesis scale>100 amino acid length peptide synthesisProvide a variety of purity specifications according to customer requirementsProvide a variety of salt types according to customer requirementsProvide a variety of resin-loaded product delivery forms according to customer requirementsProvide comprehensive and reliable analysis reports
Featured peptide synthesis:
-
Provides a library of macrocyclic peptides for selection and synthesisModifying peptide backbone structures with various linking methods and connecting groupsModification and large-scale production of non-natural amino acid structuresSynthesis of isotope labeled peptides